EGFR/TBK1-dependent mitochondrial quality control contributes to acquired resistance to temozolomideLisenn Lalier-Bretaudeau(Centre National de la Recherche Scientifique), Philippe Juin(Centre National de la Recherche Scientifique)bioRxiv (Cold Spring Harbor Laboratory)December 21, 202510.64898/2025.12.19.695123Cited by 0SaveCiteExport RISWatch citationsRelated PapersBCL-XL directly modulates RAS signalling to favour cancer cell stemness|Nature Communications|2017|46Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells|Research Square|2024|0